Non-peptidic inhibitors of neutral endopeptidase 24.11 2. Design and pharmacology of orally active phosphonate prodrugs
- 19 January 1995
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (2), 151-154
- https://doi.org/10.1016/0960-894x(94)00475-u
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Chemical and plasma hydrolyses of a diphenyl α-aminomethyl phosphonate prodrug inhibitor of neutral endopeptidase 24.11Bioorganic & Medicinal Chemistry Letters, 1994
- Pharmacological Profile of a Non-peptidic Dual Inhibitor of Neutral Endopeptidase 24.11 and Endothelin-Converting EnzymeBiochemical and Biophysical Research Communications, 1994
- Pharmacologic Profile of CGS 24128, a Potent, Long-Acting Inhibitor of Neutral Endopeptidase 24.11Journal of Cardiovascular Pharmacology, 1994
- N-Phosphonomethyl Dipeptides and Their Phosphonate Prodrugs, a New Generation of Neutral Endopeptidase (NEP, EC 3.4.24.11) InhibitorsJournal of Medicinal Chemistry, 1994
- Intramolecular participation of the amide group in acid- and base-catalysed phosphonate monoester hydrolysisJournal of the Chemical Society, Perkin Transactions 2, 1991
- Preparation of 5-tetrazolyl groups from carboxylic acids. A sequence amenable to sensitive substratesTetrahedron Letters, 1979